对《功能自发丧失突变改变小鼠结肠炎易感性且是炎症性肠病研究中的一个混杂变量》一文的修正
Correction to: Spontaneous Loss-of-Function Mutation Alters Murine Colitis Sensitivity and Is a Confounding Variable in Inflammatory Bowel Disease Research.
出版信息
Crohns Colitis 360. 2024 Sep 28;6(3):otae051. doi: 10.1093/crocol/otae051. eCollection 2024 Jul.
Abstract
[This corrects the article DOI: 10.1093/crocol/otz030.].
摘要
[本文更正了文章的数字对象标识符：10.1093/crocol/otz030。]
相似文献
1
Correction to: Spontaneous Loss-of-Function Mutation Alters Murine Colitis Sensitivity and Is a Confounding Variable in Inflammatory Bowel Disease Research.对《功能自发丧失突变改变小鼠结肠炎易感性且是炎症性肠病研究中的一个混杂变量》一文的修正
Crohns Colitis 360. 2024 Sep 28;6(3):otae051. doi: 10.1093/crocol/otae051. eCollection 2024 Jul.
2
B Cell Defects Observed in Knockout Mice Are a Consequence of a Mutation Frequently Found in Inbred Strains.在 knockout 小鼠中观察到的 B 细胞缺陷是在近交系中经常发现的 突变的结果。
J Immunol. 2018 Sep 1;201(5):1442-1451. doi: 10.4049/jimmunol.1800014. Epub 2018 Jul 16.
3
Erratum: Clinical Outcome Assessments in Pediatric Patients With Ulcerative Colitis and Crohn's Disease Receiving Biologics: A Retrospective Cohort Study.勘误：接受生物制剂治疗的溃疡性结肠炎和克罗恩病儿科患者的临床结局评估：一项回顾性队列研究。
Crohns Colitis 360. 2022 Dec 9;4(4):otac049. doi: 10.1093/crocol/otac049. eCollection 2022 Oct.
4
Correction to: Practical Primer Addressing Real-World Use Scenarios of Subcutaneous Vedolizumab in Ulcerative Colitis and Crohn's Disease: Post Hoc Analyses of VISIBLE Studies.对《溃疡性结肠炎和克罗恩病中皮下注射维多珠单抗的实际应用场景实用入门指南：VISIBLE研究的事后分析》的勘误
Crohns Colitis 360. 2023 Nov 24;5(4):otad071. doi: 10.1093/crocol/otad071. eCollection 2023 Oct.
5
Corrigendum to: Assessment of Benefit of Advanced Inflammatory Bowel Disease Training: Challenges and Solutions.
Crohns Colitis 360. 2021 Jul 28;3(3):otab037. doi: 10.1093/crocol/otab037. eCollection 2021 Jul.
6
Correction to: Risk of Primary Gastrointestinal Lymphoma in Patients With Inflammatory Conditions Exposed to Tumor Necrosis Factor Alpha Inhibitors and Immunomodulators: A Case-Control Study.
Crohns Colitis 360. 2024 May 14;6(2):otae028. doi: 10.1093/crocol/otae028. eCollection 2024 Apr.
7
Erratum: Evaluation of the Optimal Position for Vedolizumab in the Japanese Treatment Paradigm for Ulcerative Colitis Using Markov Modeling.勘误：使用马尔可夫模型评估维多珠单抗在日本溃疡性结肠炎治疗模式中的最佳位置。
Crohns Colitis 360. 2020 May 30;2(2):otaa036. doi: 10.1093/crocol/otaa036. eCollection 2020 Apr.
8
Corrigendum to: Randomized, Ascending Dose, Phase 2 Study of KHK4083, an Anti-OX40 Monoclonal Antibody, in Moderately Active Ulcerative Colitis.勘误：抗OX40单克隆抗体KHK4083用于中度活动性溃疡性结肠炎的随机、剂量递增2期研究
Crohns Colitis 360. 2020 Dec 17;2(4):otaa092. doi: 10.1093/crocol/otaa092. eCollection 2020 Oct.
9
Insights from DOCK2 in cell function and pathophysiology.DOCK2在细胞功能和病理生理学中的见解。
Front Mol Biosci. 2022 Sep 29;9:997659. doi: 10.3389/fmolb.2022.997659. eCollection 2022.
10
Correction to: Watchful Waiting After Radiological Guided Drainage of Intra-abdominal Abscess in Patients With Crohn's Disease Might Be Associated With Increased Rates of Stoma Construction.对《克罗恩病患者腹腔脓肿经放射引导引流后密切观察等待可能与造口术发生率增加相关》的更正
Crohns Colitis 360. 2023 Sep 18;5(3):otad049. doi: 10.1093/crocol/otad049. eCollection 2023 Jul.
引用本文的文献
1
PSMA-Targeted PET Radiotracer [F]DCFPyL as an Imaging Biomarker in Inflammatory Bowel Disease.PSMA靶向PET放射性示踪剂[F]DCFPyL作为炎症性肠病的成像生物标志物
Clin Exp Gastroenterol. 2023 Dec 8;16:237-247. doi: 10.2147/CEG.S404009. eCollection 2023.
2
A gut-restricted glutamate carboxypeptidase II inhibitor reduces monocytic inflammation and improves preclinical colitis.一种肠道限制性谷氨酸羧肽酶 II 抑制剂可减少单核细胞炎症并改善临床前结肠炎。
Sci Transl Med. 2023 Aug 9;15(708):eabn7491. doi: 10.1126/scitranslmed.abn7491.
Zotero 插件